The Children Leukemia Group: 30 years of research and achievements
- 31 March 2002
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38, 44-49
- https://doi.org/10.1016/s0959-8049(01)00449-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Value of High-Dose Cytarabine During Interval Therapy of a Berlin-Frankfurt-Munster–Based Protocol in Increased-Risk Children With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Results of the European Organization for Research and Treatment of Cancer 58881 Randomized Phase III TrialJournal of Clinical Oncology, 2001
- Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC reportLeukemia, 2000
- Treatment outcome in infant acute lymphoblastic leukemiaBlood, 2000
- Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group.Journal of Clinical Oncology, 1997
- Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC‐Childhood Leukaemia Cooperative GroupBritish Journal of Haematology, 1994
- Treatment of Acute Lymphoblastic Leukemia in Children with the BFM Protocol A Cooperative Pilot StudyJournal of Pediatric Hematology/Oncology, 1987
- Comparison of chemotherapy with immunotherapy for maintenance of acute lymphoblastic leukemia in children and adultsBlood, 1983
- Treatment Strategy for Different Risk Groups in Childhood Acute Lymphoblastic Leukemia: A Report From the BFM Study GroupPublished by Springer Nature ,1981